>_ QFI Terminal
TerminalStocks › XXII

22nd Century Group, Inc. (XXII) Stock

Consumer Defensive · Tobacco · US
$1.79 +1.13%
Last updated Sep 20, 2026 13:44 UTC

XXII Key Statistics

Market Cap$617,771.96
P/E (TTM)-0.01
P/S (TTM)0.06
P/B (TTM)0.02
Revenue (TTM)$9.52M
EPS (TTM)$-131.00
Dividend Yield
ROE (TTM)-20.47%
Net Margin-41.26%
Gross Margin-29.66%
52W High$646.50
52W Low$1.67
Analyst ViewBuy
Price Target$1,237.50
Employees32
Volume31,925

About 22nd Century Group, Inc.

22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.

CEO: Lawrence D. Firestone. Company website

XXII — Frequently Asked Questions

What is the XXII stock price today?

22nd Century Group, Inc. (XXII) trades at $1.79, up 1.13% on the day, as of Sep 20, 2026 13:44 UTC.

What is 22nd Century Group, Inc.'s market cap?

22nd Century Group, Inc. has a market capitalisation of $617,771.96, calculated from the live XXII share price and shares outstanding.

What is the P/E ratio of XXII?

XXII has no meaningful price-to-earnings ratio: 22nd Century Group, Inc. lost $131.00 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does 22nd Century Group, Inc. make?

22nd Century Group, Inc. generated revenue of $9.52M over the trailing twelve months, which puts the stock at 0.06 times sales.

What is the 52-week range for XXII?

XXII has traded between $1.67 and $646.50 over the past 52 weeks, and the last price is 99.7% below that high.

Is 22nd Century Group, Inc. profitable?

No. 22nd Century Group, Inc. is loss-making, with a net margin of -41.26% over the trailing twelve months.

What is the analyst price target for XXII?

Wall Street analysts rate XXII Buy, with an average price target of $1,237.50, 69,034.1% above the current price.

What sector is 22nd Century Group, Inc. in?

22nd Century Group, Inc. is classified under the Consumer Defensive sector and the Tobacco industry, and is domiciled in US.

Who is the CEO of 22nd Century Group, Inc.?

Lawrence D. Firestone is the chief executive of 22nd Century Group, Inc., which employs 32 people.

Where can I track XXII in real time?

QFI Terminal shows XXII with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See XXII live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open XXII in Terminal See plans

Tobacco stocks

PM Philip Morris International Inc. BTI British American Tobacco p.l.c. MO Altria Group, Inc. RLX RLX Technology Inc. UVV Universal Corporation

More Consumer Defensive stocks

CCU Compañía Cervecerías Unidas S.A. WMT Walmart Inc. JBS Jbs N.V. COST Costco Wholesale Corporation WYHG Wing Yip Food Holdings Group Limited American Depositary Shares KR The Kroger Co. TGT Target Corporation PEP PepsiCo, Inc.